Accelerating ALS Drug Development Through an Innovative Clinical Trial Design

In 2025 Berry will be celebrating 25 groundbreaking years in the field of statistical and adaptive clinical trials, and today we're excited to announce the launch of Berry's "In the Interim..." podcast.

This month’s webinar will be on the topic, “Why simulate? Can clinical trial simulation really improve the strategic decision making in drug development?”

Berry Consultants has hired Dr. Mike Krams as a Senior Medical Scientist in Europe, bringing extensive experience in clinical development strategy and adaptive trials to the team.

Berry Consultants has released FACTS 7.1, featuring enhancements such as concurrent control comparisons, conditional power calculations, new analysis options for dichotomous endpoints, integration with the R package "Airship" for flexible graphing, improved Bayesian dose escalation consistency, and various interface improvements.

Berry Consultants is hosting a free 6-week public webinar series on "Case Studies in using FACTS to design Clinical Trials" from October 17th to November 21st, 2024, featuring live demonstrations of trial design using their simulation software, with registration available for each session at their website.

Berry Consultants is proud to be a Principal Sponsor of the ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop in Rockville, MD from September 25th-27th, and invites attendees to visit their exhibit booth to discover their trial design, implementation, and software solutions.

In the September 6, 2024 episode of SciPod Health and Medicine, the podcast discusses a paper on Lecanemab for early Alzheimer’s disease by Dr.

Join us on August 23rd at 11am EDT for a public webinar led by FACTS developer Elias Meyer, focusing on interactive results exploration and visualization using the R Shiny App AIRSHIP; register in advance at the provided Zoom link.

Berry Consultants will sponsor the ASA JSM next week, inviting attendees to visit booth #101 for insights on adaptive clinical trial design, software demos, and to catch Dr. Joseph Marion's presentation on innovative clinical trial solutions for pediatric neurodevelopmental disorders on August 4.

Join the Berry Consultants software team on July 26 at 11am EDT for a public webinar exploring the open enrollment option in the FACTS Dose Escalation N-CRM module, including its functionality, benefits, and comparison to the BOIN "backfill" option; register in advance at the provided Zoom link.

Berry Consultants will sponsor and present at the PSI Conference in Amsterdam from June 16-19, featuring team members who will discuss various topics related to adaptive designs and clinical trials; visit booth #12 to learn more about their consulting and software solutions.

The Berry Consultants team is thrilled to present at the free Summer Biometric Seminar on June 21st at the Medical University of Vienna, focusing on "Bridging the Gap between Bayesian & Frequentist Approaches in Clinical Trials for Drug Development," with options to attend in person or online via WebEx.

Join the June 14th FACTS Software Webinar at 11am EDT for an exclusive preview of the new features in the upcoming FACTS 7.1 release, including enhanced simulators, new statistical analyses, improved graphing capabilities, and user-friendly tooltips—register in advance at the provided Zoom link.

The Berry Consultants team is eager to present at the 45th Annual Meeting of the Society for Clinical Trials in Boston, MA, with sessions on patient-centered trial design, predictive probabilities, and the HEALEY ALS Platform Trial scheduled for May 21st and 22nd.

Join the Berry Consultants Software team for an April 26 webinar at 11am EDT, where they will showcase an optimization project focused on automated design evaluation and extracting early stopping boundaries for adaptive designs; register here: https://us02web.zoom.us/webinar/register/WN_mAEuXVOATGqJE44JSrMu2w.

Join the FACTS Software March Webinar on March 22 at 11am EDT to explore Response Adaptive Randomization (RAR) through practical insights, misconceptions, and simulated examples in R and FACTS—register now!

The Berry Consultants Software team has released ADDPLAN NEO version 10.2, which introduces new features including a graph for Group Sequential designs, stopping boundaries, interim test statistic estimates from simulated trials, and illustrative examples to enhance understanding for non-statisticians.

Berry Consultants will present at the ISBS Symposium this week, featuring Dr. Christina Saunders on March 8th at 2pm EST and Dr. Kert Viele on March 9th at 1:30pm EST, with details available at the ISBS program link.

Berry Consultants will present two topics at the 2024 ENAR Spring Meeting on March 11, featuring Joe Marion, Ph.D., discussing "Borrowing Phase 2 Data in Phase 3" at 9:20am EST, and Amy Crawford, Ph.D., presenting on "Identifying Patients Who Benefit from EVT" at 10:55am EST.

Berry Consultants will host a free webinar on February 23 at 11:00 AM EST, focusing on optimizing clinical trial design and estimating the expected net present value of drug development programs using the QUOTES software, particularly addressing the trade-offs in phase 2 trials.

Join the Berry Consultants software team for their January FACTS webinar on January 19th at 11am EST to learn about the upcoming addition of an ordinal endpoint option to the trial simulator via Zoom at the provided link.

Join Dr. Cora Allen-Savietta from Berry Consultants on October 25 for a presentation on a platform trial in Parkinson's disease.

Public live Zoom webinars on "Introduction to Adaptive Trial Designs using FACTS" are scheduled for October and November.

Berry Consultants is sponsoring the ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop from September 27-29 in Rockville, MD, where several team members will be presenting, and attendees can find more information and register on the ASA Workshop Website.

The new JAMA Guide to Statistics and Methods by Dr. Barbara Wendelberger and Dr. Roger Lewis examines the concept of futility in clinical trials.

Visit the Berry Consultants booth to meet our team and experience demos of our latest software products: FACTS 7, ADDPLAN, and QUOTES.

The Berry Consultants team will present sessions on May 22 at 2:45 PM EST and May 23 at 4:15 PM EST.

On May 12, Dr. Amy Crawford and Dr. Joe Marion from Berry Consultants will present at the FDA/AdvaMed Conference.

Peter Jacko will present "Bandit Procedures for Designing Patient-Centric Clinical Trials" on April 21.

FACTS 7 introduces a new module specifically for Platform Trial designs.

Dr. Ben Saville will present at the DIA/FDA Biostatistics Industry & Regulator Forum on March 30.

The study employs Bayesian analysis to evaluate dose-finding in a Phase 2b randomized clinical trial.

Join Tom Parke for the ADMTP 2023 Workshop in Basel, Switzerland.

Register now to attend Dr. Melanie Quintana's presentation at the DIA/FDA Biostatistics Industry & Regulator Forum on March 29.

Dr. Melanie Quintana will be presenting at the MDA Clinical & Scientific Conference on March 21 at 4:30 PM CT.

Dr. Ben Saville of Berry Consultants will explore essential elements of the ENRICH randomized adaptive clinical trial.

The partnership between Berry Consultants and the NIH on the ALS Innovative Research Initiative is a remarkable endeavor aimed at advancing research in ALS.

Berry Consultants will sponsor and present at the virtual American Statistical Association's Joint Statistical Meetings from August 2-6, 2020, with more details available on the JSM website.

Since March 2020, Berry Consultants LLC has been collaborating with the Los Angeles County Department of Health Services to develop COVID-19 hospital demand modeling projections, utilizing an SEIR epidemiologic model to predict hospital needs and assess the impact of physical distancing measures, with their findings prominently featured in various media outlets.

The Los Angeles County Department of Health Services has released a COVID-19 hospital demand modeling presentation, with assistance from Berry Consultants, along with a complete press release available online.

Berry Consultants and the international REMAP-CAP team detail the Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia (REMAP-CAP) study in a manuscript published in the Annals of the American Thoracic Society.

Visit REMAPCAP.org for the latest updates and responses from the REMAP-CAP Trial regarding the COVID-19 pandemic.

Berry Consultants will sponsor and host an exhibit booth at the American Statistical Association's Joint Statistical Meetings in Denver from July 27 to August 1, 2019, where they will also present in various sessions.

Berry Consultants has launched a series of informative videos and webinars on clinical trial topics, including disease progression modeling and innovative designs, available on the ICTR website, and invites readers to register for updates and share feedback.

In a public webinar on September 20, 2018, Berry Consultants' Kert Viele will explore the key components and trade-offs of gold standard randomized clinical trials versus innovative trial designs, discussing techniques such as flexible sample sizes and novel endpoints.

Berry Consultants will prominently participate in the ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop in Washington, D.C. from September 12-14, 2018, with team members Scott Berry, Melanie Quintana, and Tom Parke presenting on various innovative topics related to clinical trial designs.

Berry Consultants will sponsor the Joint Statistical Meetings in Vancouver from July 28 to August 2, showcasing their new software FACTS 6.2 and QUOTES at exhibit booth #324, while also participating in various sessions throughout the event.

Berry Consultants is excited to announce the release of FACTS 6.1, which introduces new Dose Escalation simulation types, enhanced functionality with 'Design Variants' across all FACTS engines, and maintains full compatibility with previous versions, making it easier to estimate sample sizes and analyze trial outcomes.

Berry Consultants has launched a Clinical Trial Strategy Team, led by Dr. Meredith Buxton and Dr. Melissa Paoloni, to enhance the design and implementation of innovative platform and adaptive clinical trials across all therapeutic areas, aiming to advance precision medicine through expert guidance and comprehensive services.

Duke Clinical Research Institute is hosting a public meeting on December 7th from 9am-3pm to discuss the results of the NIH-funded ADAPT project, which aims to create a more efficient and cost-effective clinical trial design for testing new antibiotics against highly resistant bacterial pathogens.

The Clinical Trials Transformation Initiative (CTTI) has released new recommendations and best practices for Data Monitoring Committees (DMCs), with contributions from Berry Consultants' Dr. Roger Lewis and Dr. Jason Connor.

Berry Consultants will prominently sponsor and participate in the Joint Statistical Meetings (JSM) from July 30 to August 4 in Chicago, featuring an exhibit booth (#529) and various sessions, inviting attendees to meet the team.

Berry Consultants is sponsoring the Joint Statistical Meetings (JSM) from August 8-13 in Seattle, where they will host an exhibit booth (#533) and have team members presenting, with more details available in the provided summary.

The House Energy and Commerce Committee has released a discussion document proposing measures to accelerate cures in the U.S., focusing on modernizing clinical trials through Bayesian statistics and adaptive trial designs.

Dr. Donald Berry has been recognized as one of Thomson Reuters' Highly Cited Researchers in Clinical Medicine, ranking among the top 1% for most cited documents, and is also listed in "The World's Most Influential Scientific Minds: 2014."

The European Prevention of Alzheimer’s Dementia (EPAD) Initiative, involving 35 partners from industry and academia, aims to collaboratively research and test innovative treatments to prevent Alzheimer’s dementia by establishing a European-wide register of 24,000 participants over five years.

Berry Consultants will actively participate in the 2014 ASA Biopharmaceutical Section FDA-Industry Statistics Workshop in Washington D.C. from September 22-24, with team members Jason Connor, Kert Viele, and Scott Berry presenting on topics including comparative effectiveness, historical borrowing in clinical trials, and trial simulation for adaptive designs.

Berry Consultants will prominently sponsor and participate in the Joint Statistical Meetings (JSM) from August 2-7 in Boston, featuring an exhibit booth (#118) and various sessions, inviting attendees to meet their team.

Dr. Jason Connor, Director & Senior Statistical Scientist at Berry Consultants, has been selected as one of ten members of The Patient-Centered Outcomes Research Institute's Advisory Panel on Clinical Trials.

Kristine Broglio, Statistical Scientist for Berry Consultants, will present at two conferences in June 2014: the ISPOR 19th Annual International Meeting on May 31-June 4, discussing "Determining Comparative Effectiveness Benchmarks for Emerging Treatments for Hepatitis C Virus," and the DIA 2014 50th Annual Meeting on June 15-19.

Berry Consultants has acquired full ownership of the FACTS clinical trial simulation software from Tessella, enhancing its capabilities in designing advanced clinical trials while Tessella will continue to provide IT support during the transition.

Our News & Events section now features two new articles on adaptive design for trials, including "Adaptive Clinical Design Addresses the Uncertainties" and "How Math Can Improve Drug Trials and Save Lives," with direct links available.

Berry Consultants will present at two London conferences in 2014: "Adaptive Designs in Clinical Trials" on March 24-25 featuring Dr. Roger Lewis, and "Smart Trials 2014" on April 9-10 with Anna McGlothlin, focusing on innovative approaches in clinical development.

Berry Consultants will sponsor and host an exhibit booth at the Joint Statistical Meetings (JSM) in Montreal from August 3-8, 2013, where team members will participate in various sessions, with more details available on their website.

Berry Consultants is co-sponsoring the "Transforming Drug Development" conference on October 22nd in Bethesda, Maryland, featuring key presentations from team members on adaptive clinical trials, and interested attendees can register at http://www.InnovationsInClinicalTrials.com/.

In April, Berry Consultants will participate in several events, including conferences and webinars on adaptive designs and comparative effectiveness trials, taking place in London, Bethesda, and Arlington.

Berry Consultants is co-sponsoring the "Transforming Drug Development" conference on October 22nd in Bethesda, Maryland, featuring key presentations from team members on adaptive clinical trials, and interested attendees can register at http://www.InnovationsInClinicalTrials.com/.